My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 237

    1.

    HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.

    Blom DJ, Schurmans LR, De Waard-Siebinga I, De Wolff-Rouendaal D, Keunen JE, Jager MJ.

    Br J Ophthalmol. 1997 Nov;81(11):989-93.PMID: 9505825 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HLA expression and tumor-infiltrating immune cells in uveal melanoma.

    de Waard-Siebinga I, Hilders CG, Hansen BE, van Delft JL, Jager MJ.

    Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):34-42.PMID: 8750848 [PubMed - indexed for MEDLINE]Related articles

    3.

    HLA antigen expression on uveal melanoma cells in vivo and in vitro.

    de Waard-Siebinga I, Kool J, Jager MJ.

    Hum Immunol. 1995 Oct;44(2):111-7.PMID: 8847229 [PubMed - indexed for MEDLINE]Related articles

    4.

    Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.

    Kageshita T, Ishihara T, Campoli M, Ferrone S.

    Tissue Antigens. 2005 May;65(5):419-28.PMID: 15853896 [PubMed - indexed for MEDLINE]Related articles

    5.

    Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.

    Ma D, Luyten GP, Luider TM, Niederkorn JY.

    Invest Ophthalmol Vis Sci. 1995 Feb;36(2):435-41.PMID: 7843912 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Uveal melanoma: no expression of HLA-G.

    Hurks HM, Valter MM, Wilson L, Hilgert I, van den Elsen PJ, Jager MJ.

    Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3081-4.PMID: 11726606 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    HLA expression in uveal melanoma: there is no rule without some exception.

    Jager MJ, Hurks HM, Levitskaya J, Kiessling R.

    Hum Immunol. 2002 Jun;63(6):444-51. Review.PMID: 12039519 [PubMed - indexed for MEDLINE]Related articles

    8.

    Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.

    Natali PG, Bigotti A, Nicotra MR, Nardi RM, Delovu A, Segatto O, Ferrone S.

    Cancer Res. 1989 Mar 1;49(5):1269-74.PMID: 2917356 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.

    Hurks HM, Metzelaar-Blok JA, Mulder A, Claas FH, Jager MJ.

    Int J Cancer. 2000 Mar 1;85(5):697-702.PMID: 10699951 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

    Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J.

    Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2888-95. Epub 2009 Feb 21.PMID: 19234348 [PubMed - indexed for MEDLINE]Related articles

    11.

    Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.

    Krishnakumar S, Abhyankar D, Sundaram AL, Pushparaj V, Shanmugam MP, Biswas J.

    Clin Cancer Res. 2003 Sep 15;9(11):4159-64.PMID: 14519640 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.

    Kovalcsik E, John J, Turner M, Birchall L, Sage D, Whittle R, Dalgleish A, Pandha H.

    Melanoma Res. 2004 Dec;14(6):463-71.PMID: 15577316 [PubMed - indexed for MEDLINE]Related articles

    13.

    Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

    Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S.

    Cancer Res. 1993 Jul 15;53(14):3349-54.PMID: 7686817 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Association of HLA class I and class II antigen expression and mortality in uveal melanoma.

    Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O.

    Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2153-6.PMID: 11527924 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.

    de Waard-Siebinga I, Creyghton WM, Kool J, Jager MJ.

    Br J Ophthalmol. 1995 Sep;79(9):847-55.PMID: 7488605 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Infiltrating lymphocytes and antigen expression in uveal melanoma.

    Meecham WJ, Char DH, Kaleta-Michaels S.

    Ophthalmic Res. 1992;24(1):20-6.PMID: 1608588 [PubMed - indexed for MEDLINE]Related articles

    17.

    Expression of classic and nonclassic HLA class I antigens in uveal melanoma.

    Anastassiou G, Rebmann V, Wagner S, Bornfeld N, Grosse-Wilde H.

    Invest Ophthalmol Vis Sci. 2003 May;44(5):2016-9.PMID: 12714638 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.

    Carrel S, Schreyer M, Gross N, Zografos L.

    Anticancer Res. 1990 Jan-Feb;10(1):81-9.PMID: 1692197 [PubMed - indexed for MEDLINE]Related articles

    19.

    Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.

    Maio M, Gulwani B, Tombesi S, Ferrone S.

    Cancer Immunol Immunother. 1989;30(1):34-42.PMID: 2513111 [PubMed - indexed for MEDLINE]Related articles

    20.

    MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.

    Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S.

    Cancer Res. 2007 May 1;67(9):4499-506.PMID: 17483366 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity